Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction
Leigh V. Panlilio, Zuzana Justinová, Steven R. Goldberg
Pharmacology & Therapeutics (2013) Vol. 138, Iss. 1, pp. 84-102
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Endocannabinoid signalling in reward and addiction
Loren H. Parsons, Yasmin L. Hurd
Nature reviews. Neuroscience (2015) Vol. 16, Iss. 10, pp. 579-594
Open Access | Times Cited: 420
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Ozge Gunduz‐Cinar, Matthew N. Hill, Bruce S. McEwen, et al.
Trends in Pharmacological Sciences (2013) Vol. 34, Iss. 11, pp. 637-644
Open Access | Times Cited: 210
Lipids in psychiatric disorders and preventive medicine
Miriam Schneider, Beth Levant, Martin Reichel, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 76, pp. 336-362
Open Access | Times Cited: 151
The Endocannabinoid Signaling System in the CNS
Cecilia J. Hillard
International review of neurobiology (2015), pp. 1-47
Open Access | Times Cited: 111
Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal
Chandni Hindocha, Tom P. Freeman, Meryem Grabski, et al.
Addiction (2018) Vol. 113, Iss. 9, pp. 1696-1705
Open Access | Times Cited: 98
The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury
Flaubert Tchantchou, Laura B. Tucker, Amanda H. Fu, et al.
Neuropharmacology (2014) Vol. 85, pp. 427-439
Open Access | Times Cited: 95
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence
Primavera A. Spagnolo, Vijay A. Ramchandani, Melanie L. Schwandt, et al.
Alcoholism Clinical and Experimental Research (2016) Vol. 40, Iss. 11, pp. 2426-2434
Open Access | Times Cited: 88
A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents
Rati Kailash Prasad Tripathi
European Journal of Medicinal Chemistry (2019) Vol. 188, pp. 111953-111953
Closed Access | Times Cited: 76
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
Giulia Abate, Daniela Uberti, Simone Tambaro
Biology (2021) Vol. 10, Iss. 6, pp. 542-542
Open Access | Times Cited: 71
Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse
Zuzana Justinová, Leigh V. Panlilio, Guillermo Moreno‐Sanz, et al.
Neuropsychopharmacology (2015) Vol. 40, Iss. 9, pp. 2185-2197
Open Access | Times Cited: 84
Cannabis: A Treasure Trove or Pandora's Box?
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone
Adam Bisaga, Maria A. Sullivan, Andrew Glass, et al.
Drug and Alcohol Dependence (2015) Vol. 154, pp. 38-45
Open Access | Times Cited: 83
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review
Marta Kruk-Słomka, Agnieszka Dzik, Barbara Budzyńska, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 10, pp. 8332-8347
Open Access | Times Cited: 80
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB
Isabelle Boileau, Esmaeil Mansouri, Belinda Williams, et al.
Biological Psychiatry (2016) Vol. 80, Iss. 9, pp. 691-701
Open Access | Times Cited: 70
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
Natalie E. Zlebnik, Joseph F. Cheer
Annual Review of Neuroscience (2016) Vol. 39, Iss. 1, pp. 1-17
Open Access | Times Cited: 65
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29
A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice
Talita H. Ferreira‐Vieira, Cristiane Perácio Bastos, Grace Schenatto Pereira, et al.
Hippocampus (2013) Vol. 24, Iss. 1, pp. 79-88
Closed Access | Times Cited: 62
Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat
Harald S. Hansen
Pharmacological Research (2014) Vol. 86, pp. 18-25
Closed Access | Times Cited: 59
Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review
Jan Copeland, Izabella Pokorski
Substance Abuse and Rehabilitation (2016), pp. 41-41
Open Access | Times Cited: 53
Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety
Andalib Danandeh, Valentina Vozella, James Lim, et al.
Psychopharmacology (2018) Vol. 235, Iss. 11, pp. 3211-3221
Closed Access | Times Cited: 50
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 50
Classical endocannabinoid‐like compounds and their regulation by nutrients
Karen Kleberg, Helle A. Hassing, Harald S. Hansen
BioFactors (2014) Vol. 40, Iss. 4, pp. 363-372
Closed Access | Times Cited: 50
Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats
Parisa Hasanein, Massoud Teimuri Far
Pharmacology Biochemistry and Behavior (2015) Vol. 131, pp. 130-135
Closed Access | Times Cited: 48
The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs—A practical view
Christopher J. Fowler
European Neuropsychopharmacology (2015) Vol. 25, Iss. 6, pp. 749-762
Closed Access | Times Cited: 47
Blockade of alcohol escalation and “relapse” drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice
Yan Zhou, Benjamin I. Schwartz, Joanna Giza, et al.
Psychopharmacology (2017) Vol. 234, Iss. 19, pp. 2955-2970
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top